172 related articles for article (PubMed ID: 17826030)
1. Vasoactive intestinal peptide inhibits cyclooxygenase-2 expression in activated macrophages, microglia, and dendritic cells.
Gonzalez-Rey E; Delgado M
Brain Behav Immun; 2008 Jan; 22(1):35-41. PubMed ID: 17826030
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
Delgado M; Jonakait GM; Ganea D
Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in endotoxin-activated microglia.
Delgado M
Biochem Biophys Res Commun; 2002 May; 293(2):771-6. PubMed ID: 12054537
[TBL] [Abstract][Full Text] [Related]
4. Phellinus linteus inhibits inflammatory mediators by suppressing redox-based NF-kappaB and MAPKs activation in lipopolysaccharide-induced RAW 264.7 macrophage.
Kim HG; Yoon DH; Lee WH; Han SK; Shrestha B; Kim CH; Lim MH; Chang W; Lim S; Choi S; Song WO; Sung JM; Hwang KC; Kim TW
J Ethnopharmacol; 2007 Dec; 114(3):307-15. PubMed ID: 17936530
[TBL] [Abstract][Full Text] [Related]
5. 5-Chloroacetyl-2-amino-1,3-selenazoles attenuate microglial inflammatory responses through NF-kappaB inhibition.
Nam KN; Koketsu M; Lee EH
Eur J Pharmacol; 2008 Jul; 589(1-3):53-7. PubMed ID: 18538761
[TBL] [Abstract][Full Text] [Related]
6. Withaferin A down-regulates lipopolysaccharide-induced cyclooxygenase-2 expression and PGE2 production through the inhibition of STAT1/3 activation in microglial cells.
Min KJ; Choi K; Kwon TK
Int Immunopharmacol; 2011 Aug; 11(8):1137-42. PubMed ID: 21396905
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kappaB in human prostate cell lines Differential time-dependent responses in cancer progression.
Fernández-Martínez AB; Collado B; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
Mol Cell Endocrinol; 2007 May; 270(1-2):8-16. PubMed ID: 17434257
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels.
Delgado M; Varela N; Gonzalez-Rey E
Glia; 2008 Aug; 56(10):1091-103. PubMed ID: 18442091
[TBL] [Abstract][Full Text] [Related]
9. VIP limits LPS-induced nitric oxide production through IL-10 in NOD mice macrophages.
Larocca L; Calafat M; Roca V; Franchi AM; Leirós CP
Int Immunopharmacol; 2007 Oct; 7(10):1343-9. PubMed ID: 17673149
[TBL] [Abstract][Full Text] [Related]
10. Role of vasoactive intestinal peptide in inflammation and autoimmunity.
Gonzalez-Rey E; Delgado M
Curr Opin Investig Drugs; 2005 Nov; 6(11):1116-23. PubMed ID: 16312132
[TBL] [Abstract][Full Text] [Related]
11. Diarctigenin, a lignan constituent from Arctium lappa, down-regulated zymosan-induced transcription of inflammatory genes through suppression of DNA binding ability of nuclear factor-kappaB in macrophages.
Kim BH; Hong SS; Kwon SW; Lee HY; Sung H; Lee IJ; Hwang BY; Song S; Lee CK; Chung D; Ahn B; Nam SY; Han SB; Kim Y
J Pharmacol Exp Ther; 2008 Nov; 327(2):393-401. PubMed ID: 18694995
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide inhibits toll-like receptor 3-induced nitric oxide production in Schwann cells and subsequent sensory neuronal cell death in vitro.
Lee H; Park K; Kim JS; Lee SJ
J Neurosci Res; 2009 Jan; 87(1):171-8. PubMed ID: 18683246
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide suppresses toll-like receptor 4 expression in macrophages via Akt1 reducing their responsiveness to lipopolysaccharide.
Arranz A; Androulidaki A; Zacharioudaki V; Martinez C; Margioris AN; Gomariz RP; Tsatsanis C
Mol Immunol; 2008 May; 45(10):2970-80. PubMed ID: 18336909
[TBL] [Abstract][Full Text] [Related]
14. Regulatory effects of vasoactive intestinal peptide on the migration of mature dendritic cells.
Weng Y; Sun J; Wu Q; Pan J
J Neuroimmunol; 2007 Jan; 182(1-2):48-54. PubMed ID: 17081624
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide (VIP) receptor expression in monocyte-derived macrophages from COPD patients.
Burian B; Storka A; Marzluf BA; Yen YC; Lambers C; Robibaro B; Vonbank K; Mosgoeller W; Petkov V
Peptides; 2010 Apr; 31(4):603-8. PubMed ID: 20026142
[TBL] [Abstract][Full Text] [Related]
16. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.
Delgado M; Robledo G; Rueda B; Varela N; O'Valle F; Hernandez-Cortes P; Caro M; Orozco G; Gonzalez-Rey E; Martin J
Arthritis Rheum; 2008 Apr; 58(4):1010-9. PubMed ID: 18383379
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of age-associated up-regulation in macrophage PGE2 synthesis.
Wu D; Meydani SN
Brain Behav Immun; 2004 Nov; 18(6):487-94. PubMed ID: 15331118
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of iNOS in an LPS-stimulated macrophage model by omega-3 fatty acids is independent of COX-2 derived PGE2.
Razzak A; Aldrich C; Babcock TA; Saied A; Espat NJ
J Surg Res; 2008 Apr; 145(2):244-50. PubMed ID: 18067925
[TBL] [Abstract][Full Text] [Related]
19. Fermented guava leaf extract inhibits LPS-induced COX-2 and iNOS expression in Mouse macrophage cells by inhibition of transcription factor NF-kappaB.
Choi SY; Hwang JH; Park SY; Jin YJ; Ko HC; Moon SW; Kim SJ
Phytother Res; 2008 Aug; 22(8):1030-4. PubMed ID: 18618521
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effect of allylpyrocatechol in LPS-induced macrophages is mediated by suppression of iNOS and COX-2 via the NF-kappaB pathway.
Sarkar D; Saha P; Gamre S; Bhattacharjee S; Hariharan C; Ganguly S; Sen R; Mandal G; Chattopadhyay S; Majumdar S; Chatterjee M
Int Immunopharmacol; 2008 Sep; 8(9):1264-71. PubMed ID: 18602073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
